Urinary cytology changes in protease inhibitor induced urolithiasis.
Hamm
M
M
Department of Urology, Augsburg Central Hospital, Germany.
Wawroschek
F
F
Rathert
P
P
D000328:Adult; D002295:Carcinoma, Transitional Cell / Q000150:complications* / Q000473:pathology*; D017320:HIV Protease Inhibitors / Q000009:adverse effects*; D006801:Humans; D019469:Indinavir / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D014514:Ureteral Calculi / Q000139:chemically induced* / Q000150:complications*; D014556:Urine / Q000166:cytology*; D014571:Urologic Neoplasms / Q000150:complications* / Q000473:pathology*
D017320:HIV Protease Inhibitors; D019469:Indinavir